All 42 CDSCO Forms, Decoded

Low and moderate-risk medical devices regulated under the State Licensing Authority. Includes manufacturing and loan licences. Issued by your State Drugs Controller and valid perpetually until suspended or cancelled — no fixed-period renewals. Typical approval window is 4–6 weeks for a clean application with the QMS and site readiness already in place.

High-risk medical devices regulated centrally by CDSCO. Includes manufacturing and loan licences with deeper QMS scrutiny. Requires an ISO 13485-aligned quality system, an in-house testing infrastructure, and a joint inspection by CDSCO and State authorities. Expect 6–9 months end-to-end once the technical file is complete, with classification rationale being the most scrutinised section of the dossier.

CDSCO import licences for foreign-manufactured medical devices distributed in India. Filed by Indian importers or Authorised Indian Agents. Requires a valid Free-Sale Certificate from the country of origin, an India-based AIA with a registered office, and product registration evidence. Granted per product family and remains valid until suspended, with variations and re-export records reviewed periodically.

Licences to manufacture medical devices specifically for clinical investigations, testing, evaluation, demonstration, or training purposes. Restricted-purpose authorisations — devices produced under them cannot be commercialised. Required upstream of a clinical investigation permission (MD-22) and tied to the protocol approved by CDSCO. Typical use cases include investigator-initiated trials, pivotal studies, and engineering builds for design verification.

Import licences for clinical investigations, government-hospital investigational use, and personal-use small-quantity imports. Quantity-limited and purpose-specific — not for commercial distribution. Common pathways for early-access devices, investigator-initiated studies, and personal medical needs not yet served by Indian market approvals. Each route has distinct documentation rules, justification thresholds, and post-import reporting obligations.

CDSCO permissions to conduct clinical investigations of investigational medical devices and Performance Evaluation Reports for new IVDs. Requires an approved protocol, ethics-committee clearance from each participating site, registered investigators, and a clinical-trial insurance policy. Mandatory for any device claiming a unique indication or seeking pre-market clinical evidence in India. Approval timelines run 3–6 months and are tied to dossier completeness rather than the device class.

Permissions to import or manufacture medical devices without an existing predicate, and new in-vitro diagnostic devices entering the Indian market. The first-of-its-kind regulatory pathway — used when no equivalent device is already classified. Involves an expert-committee review, additional clinical or analytical evidence, and a formal CDSCO classification decision before commercial licensing. Best engaged with early so the classification rationale shapes the downstream licence dossier.

Registration of notified bodies with CDSCO under the Medical Devices Rules, 2017 — for conformity assessment and audit-conducting organisations. Once registered, the body can inspect Class A and Class B manufacturers on behalf of CDSCO. Requires demonstrated technical competence, a qualified auditor pool, and a documented quality management system aligned with ISO/IEC 17021. Renewals depend on ongoing audit-performance evidence and impartiality reviews.

CDSCO registration for laboratories conducting tests or evaluations on behalf of medical device manufacturers. Required for any lab issuing test reports used in CDSCO licensing dossiers. Demands NABL accreditation in the relevant test scopes, calibrated instrumentation, trained analytical staff, and an audit history acceptable to the Central Licensing Authority. Maintained through periodic surveillance audits and scope renewals.

Forms used for submitting devices to the Central Medical Device Testing Laboratory for evaluation and certification. The reference pathway when private-lab test reports are challenged or when a device falls under CDSCO's mandatory central-testing list. Reports issued here carry primary regulatory weight in approval, dispute, and enforcement matters. Lead times depend on the test discipline, sample availability, and queue at the central facility.

State-level licences for wholesale and retail sale, stocking, and distribution of medical devices across India. Granted by the State Drugs Controller of the state where the premises are located — a separate licence is required per state of operation. Mandatory before any commercial sale of imported or domestically-manufactured devices through your channel. Compliance hinges on qualified competent person credentials, premises layout, and complete distribution records.

Forms used for ongoing audit-book maintenance and regulatory enforcement actions under the Medical Devices Rules and Drugs and Cosmetics Act. Cover routine inspection logbooks, observation responses, show-cause notices, and licence suspension or cancellation procedures. Maintained perpetually post-licence — gaps in these records are the single biggest cause of renewal failures and re-inspection escalations. Treat them as a living compliance trail, not a one-time filing.